Novartis AG (NYSE:NVS)

96.87
Data as of Jan 23
 +0.03 / +0.03%
Today’s Change
77.90
Today|||52-Week Range
102.59
+4.54%
Year-to-Date
These 3 Pharmaceutical Companies Control Roughly Half of All Cancer Drug Sales
8:04am / MotleyFool.com
Novartis' Cosentyx Approved in Europe for Plaque Psoriasis - Analyst Blog
Jan 20 / Zacks.com
Novartis AG ADR (NVS): New Analyst Report from Zacks Equity Research - Zacks Equity R...
12:01am / Zacks.com
Can AbbVie Inc. Overcome Humirabs Looming Patent Expiration?
Jan 20 / MotleyFool.com
This Study Offers a Terrifying Revelation on the Future Cost of Cancer
Jan 24 / MotleyFool.com
Ebola Vaccine Sends Johnson & Johnson Stock Higher Ahead of Earnings
Jan 19 / TheStreet.com
This Stock Could Become the Next Johnson & Johnson
Jan 24 / MotleyFool.com
5 Tiny Biotech Stocks to Own in 2015
Jan 17 / MotleyFool.com
Novartis AG ADR (NVS): New Analyst Report from Zacks Equity Research - Zacks Equity R...
Jan 24 / Zacks.com
Swiss companies and currency brokers bleed
Jan 16 / CNNMoney.com
Will Novartis' (NVS) Earnings Disappoint Expectations in Q4? - Analyst Blog
Jan 23 / Zacks.com
6 Stocks Riding the Swiss Franc Surge - Stocks in the News
Jan 15 / Zacks.com
Novartis AG ADR (NVS): New Analyst Report from Zacks Equity Research - Zacks Equity R...
Jan 23 / Zacks.com
3 Slides That Tell You Everything You Need to Know About GlaxoSmithKline PLC
Jan 15 / MotleyFool.com
Why Shares Of Array Biopharma Are Surging More Than 35%
Jan 23 / Benzinga
Can You Guess Which Big Pharma Has a More Robust Pipeline Than Pfizer, Inc.?
Jan 15 / MotleyFool.com
Why Array Biopharma Inc's Shares Skyrocketed
Jan 23 / MotleyFool.com
Roche to Acquire Up to 56% Interest in Foundation Medicine - Analyst Blog
Jan 14 / Zacks.com
Novartis CEO: Supporting Affordable Care Act Supports Insuring Americans
Jan 23 / Benzinga
ARIAD Reveals 2015 Strategic Objectives, Updates on Pipeline - Analyst Blog
Jan 14 / Zacks.com
Novartis' Psoriasis Drug Cosentyx Gets FDA Approval - Analyst Blog
Jan 22 / Zacks.com
Why Investors are Excited About Intrexon and Ziopharm's New Deal
Jan 14 / MotleyFool.com
Novartis (NVS) Weak In Early Morning Trading
Jan 22 / TheStreet.com
Novartis Submits NDA for Ultibro & Seebri Breezhaler - Analyst Blog
Jan 12 / Zacks.com
Teva Up on Positive Copaxone Supreme Court Ruling - Analyst Blog
Jan 21 / Zacks.com
5 Predictions for Biotechnology Stocks in 2015
Jan 11 / MotleyFool.com
State of the Union Address Investing Idea: Precision Medicine
Jan 21 / MotleyFool.com
 

Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer.

Morningstar: © 2015 Morningstar, Inc. All Rights Reserved.

Factset: FactSet Research Systems Inc. 2015. All rights reserved.

Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved.

Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Standard & Poor's and S&P are registered trademarks of Standard & Poor’s Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2015 and/or its affiliates.